Canaccord Equity

A day after Exa Corp (NASDAQ: EXA) provided an earnings surprises for the fourth straight quarter, Canaccord Equity analysts David Hynes, Richard Davis and Mark Belcarz said there was no change in the firm's Buy thesis. However, the analysts have boosted the price target from $15 to $18. The...